Clinical Trial: Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Observational

Official Title: Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid T

Brief Summary:

RATIONALE: Studying biomarkers of tissue samples from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor.

Detailed Summary:

OBJECTIVES:

Primary

• To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK) and the atypical teratoid rhabdoid tumor (ATRT).

OUTLINE: Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.

Sponsor: Children's Oncology Group

Current Primary Outcome: Molecular differences between RTK and the ATRT

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Children's Oncology Group

Dates:
Date Received: October 1, 2011
Date Started: September 2011
Date Completion:
Last Updated: February 19, 2016
Last Verified: February 2016